The presence of intratumoral heterogeneity makes it plausible that a subset of tumor cells is resistant to the antitumorigenic effects of IFNγ, yet is sensitive to other IFNγ-driven responses, including partial or full EMT. This evidence concerns the gene IFNG and neoplasm.